RETX resulted in significant improvements in survival in a large series of liver transplant patients. One-year survival following RETX is not as good as following primary transplants, but the rate approaches 50% for all patients, 60% for children, and 45% for adults. RETX occurs in a variety of clinical settings but results from one of three major causes: rejection, PNF, or TECs. The need for RETX can be emergent, acute, or elective. The decision for RETX is usually obvious in the emergent and acute settings. Guidelines for making the decision in the elective situation have been outlined.
|Original language||English (US)|
|Number of pages||8|
|Issue number||1 I|
|State||Published - Jan 1 1985|
ASJC Scopus subject areas